Ashwagandha (KSM-66)
A 2012 RCT in chronically stressed adults (Chandrasekhar et al., KSM-66 600mg/day, 60 days; extract supplied by its maker Ixoreal Biomed) found serum cortisol fell 27.9% versus 7.9% on placebo and perceived stress fell 44%. A 2024 meta-analysis of 9 RCTs confirmed significant reductions in perceived stress, anxiety and cortisol, though a 2019 crossover trial of a low-dose extract in older overweight men found no cortisol effect. A 2017 RCT (Choudhary et al., 300mg twice daily, 8 weeks) improved memory and executive function — in adults with mild cognitive impairment, not healthy adults. Liver-injury case reports exist, and Denmark banned ashwagandha supplements in 2023.
エビデンス確認日:
作用機序
Ashwagandha (Withania somnifera) is an Ayurvedic adaptogen. Its withanolides modulate the HPA axis to reduce cortisol, while also inhibiting acetylcholinesterase (preserving acetylcholine) and promoting GABA receptor activity for anxiolytic effects. KSM-66 is the most studied full-spectrum root extract.
臨床エビデンスの概要
A 2012 RCT in chronically stressed adults (Chandrasekhar et al., KSM-66 600mg/day, 60 days; extract supplied by its maker Ixoreal Biomed) found serum cortisol fell 27.9% versus 7.9% on placebo and perceived stress fell 44%. A 2024 meta-analysis of 9 RCTs confirmed significant reductions in perceived stress, anxiety and cortisol, though a 2019 crossover trial of a low-dose extract in older overweight men found no cortisol effect. A 2017 RCT (Choudhary et al., 300mg twice daily, 8 weeks) improved memory and executive function — in adults with mild cognitive impairment, not healthy adults. Liver-injury case reports exist, and Denmark banned ashwagandha supplements in 2023.
ヒト効果マトリクス
Based on human clinical trials only. Animal and in-vitro data excluded.
| 効果 | エビデンス | 効果の大きさ | 研究数 |
|---|---|---|---|
| Cortisol Reduction | strong | 大 | 3 |
| Anxiety & Stress | strong | 大 | 2 |
| Sleep Quality | moderate | 中 | — |
| Memory (Mild Cognitive Impairment) | preliminary | 中 | 1 |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
実証された効果
- Cortisol reduction
- Lower perceived stress and anxiety
- Memory in mild cognitive impairment (one 8-week RCT)
- Sleep quality
- Muscle strength and recovery
副作用と注意事項
- Generally well tolerated in 8–12 week trials
- GI upset in some users
- Liver injury: published case reports and case series, including cases scored "probable" on the RUCAM causality scale that resolved after stopping — stop and see a doctor if you notice jaundice or dark urine
- Denmark banned ashwagandha food supplements in 2023 because a safe dose could not be established
- Contraindicated in thyroid conditions
- Avoid during pregnancy
摂取方法
スタッキングの推奨
Ashwagandha (KSM-66)と相性の良い成分とその理由。
The canonical adaptogen duo. Rhodiola is activating (morning); Ashwagandha is calming (evening). Both target HPA axis dysregulation but through different mechanisms and at different times of day — a perfect day/night pair.
Both reduce anxiety through distinct mechanisms (HPA axis modulation vs. GABA modulation). L-Theanine provides immediate calm; Ashwagandha provides systemic, longer-term stress reduction. Together they work at multiple timescales.
Both independently reduce cortisol via different pathways (HPA modulation vs. cortisol receptor sensitivity). The combination may provide additive cortisol reduction under high-stress conditions.
よくある質問
KSM-66 vs Sensoril vs generic ashwagandha — which should I choose?
KSM-66 (5% withanolides from root only) is the extract used in the key stress and cognition trials. Sensoril (8% withanolides from root + leaf, lower dose needed at 125–250mg) has good evidence specifically for stress and sleep. Generic ashwagandha without a stated withanolide percentage is unreliable — you may be paying for starchy root powder with minimal active content. Choose KSM-66 or Sensoril.
Will ashwagandha make me tired during the day?
No — at morning doses, most people experience calm focus, not sedation. The tiredness effect is most pronounced when taken at night, where it reduces sleep latency. Ashwagandha doesn't deplete energy; it reduces the cortisol-driven hyperarousal that causes fatigue. Some people find 600mg in the morning slightly sedating — if so, reduce to 300mg or shift to evening only.
Is ashwagandha safe for long-term use?
Long-term data is missing: most trials run 8–12 weeks, and no controlled safety data beyond about 90 days was found. Published case reports link ashwagandha to liver injury (some scored "probable" on the RUCAM causality scale), and Denmark banned ashwagandha food supplements in 2023 because a safe dose could not be established. Stop and see a doctor if you develop jaundice or dark urine. Avoid if you have thyroid conditions (autoimmune thyroid disease) as withanolides can modulate thyroid hormone levels.
Can ashwagandha increase testosterone?
Two RCTs found increases: 600mg/day for 8 weeks in young men starting resistance training raised testosterone alongside greater strength gains (2015), and a crossover trial in overweight men aged 40–70 found testosterone +14.7% and DHEA-S +18% versus placebo — but no change in cortisol, fatigue or vigour (Lopresti 2019). The magnitude varies by population and extract.
Top stacks containing Ashwagandha (KSM-66)
Ashwagandha (KSM-66) in Japan
Products in Japan
Consumer Affairs Agency (FFC)
Regulatory note
本ページは教育目的の編集コンテンツであり、医学的助言を構成するものではありません。日本国内で販売される機能性表示食品(FFC)および特定保健用食品(FOSHU)は、消費者庁への届出または許可を必要とします。届出のない輸入品については、日本の薬機法(旧薬事法)の下で疾病治療を示唆する表現は規制されます。サプリメントを開始する前に、必ず資格のある医療専門家にご相談ください。This page is editorial and not medical advice. Foods with Function Claims (FFC) and Foods for Specified Health Uses (FOSHU) sold in Japan require notification or approval from the Consumer Affairs Agency. Imported products without notification cannot make disease-treatment claims under the Pharmaceuticals and Medical Devices (PMD) Act. Note: In July 2026, the Consumer Affairs Agency (CAA) opened a public comment period (Notice No. 235080088, closes 30 July 2026) on proposed revisions to permitted claim wording for FFC-notified ingredients including DHA, phosphatidylserine, and NMN; compliant claim language may require updating once the final Cabinet Office Order is published. Consult a qualified healthcare professional before starting any supplement.
出典 (8)展開
- PMID 23439798A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. (2012)
- PMID 39348746Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis. (2024)
- PMID 28471731Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions. (2017)
- PMID 26609282Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. (2015)
- PMID 30854916A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha in Aging, Overweight Males. (2019)
- PMID 37631044Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause. (2023)
- PMID 36900932Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury. (2023)
- PMID 38969606Danish ban on Ashwagandha: Truth, evidence, ethics, and regulations. (2024)